Francesco Favero
Francesco Favero
Verified email at bric.ku.dk - Homepage
Title
Cited by
Cited by
Year
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
N McGranahan, F Favero, EC de Bruin, NJ Birkbak, Z Szallasi, C Swanton
Science translational medicine 7 (283), 283ra54-283ra54, 2015
3812015
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ...
Annals of Oncology 26 (1), 64-70, 2015
2422015
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications
S Busacca, S Germano, L De Cecco, M Rinaldi, F Comoglio, F Favero, ...
American journal of respiratory cell and molecular biology 42 (3), 312-319, 2010
1702010
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
1372020
Targeting human cancer by a glycosaminoglycan binding malaria protein
A Salanti, TM Clausen, MØ Agerbæk, N Al Nakouzi, M Dahlbäck, HZ Oo, ...
Cancer cell 28 (4), 500-514, 2015
1012015
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
AM Marquard, AC Eklund, T Joshi, M Krzystanek, F Favero, ZC Wang, ...
Biomarker research 3 (1), 9, 2015
692015
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
R Fisher, S Horswell, A Rowan, MP Salm, EC de Bruin, S Gulati, ...
Genome biology 15 (8), 1-15, 2014
652014
BCL9L dysfunction impairs caspase-2 expression permitting aneuploidy tolerance in colorectal cancer
C López-García, L Sansregret, E Domingo, N McGranahan, S Hobor, ...
Cancer cell 31 (1), 79-93, 2017
532017
Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells
C Belgiovine, R Frapolli, K Bonezzi, I Chiodi, F Favero, M Mello-Grand, ...
PloS one 5 (11), e14154, 2010
532010
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories
C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ...
Cancer Cell 34 (6), 996-1011. e8, 2018
382018
Mitochondrial mutations drive prostate cancer aggression
JF Hopkins, VY Sabelnykova, J Weischenfeldt, R Simon, JA Aguiar, ...
Nature communications 8 (1), 1-8, 2017
332017
TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen
AM Marquard, NJ Birkbak, CE Thomas, F Favero, M Krzystanek, ...
BMC medical genomics 8 (1), 58, 2015
282015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F Favero, N McGranahan, M Salm, NJ Birkbak, JZ Sanborn, SC Benz, ...
Annals of Oncology 26 (5), 880-887, 2015
232015
Synthesis of 5‐Selenoxo‐1, 2, 4‐triazole‐1‐carboxylates from Isoselenocyanates and Azodicarboxylates.
F Favero, GL Sommen, A Linden, H Heimgartner
Heterocycles 67 (2), 749-762, 2006
162006
Large-scale uniform analysis of cancer whole genomes in multiple computing environments
CK Yung, BD O’Connor, S Yakneen, J Zhang, K Ellrott, K Kleinheinz, ...
BioRxiv, 161638, 2017
142017
Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality
JW Hansen, DA Pedersen, LA Larsen, S Husby, SB Clemmensen, ...
blood 135 (4), 261-268, 2020
112020
Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
Z Sztupinszki, M Diossy, M Krzystanek, L Reiniger, I Csabai, F Favero, ...
NPJ breast cancer 4 (1), 1-4, 2018
112018
Butler enables rapid cloud-based analysis of thousands of human genomes
S Yakneen, SM Waszak, M Gertz, JO Korbel
Nature biotechnology 38 (3), 288-292, 2020
52020
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
S Husby, F Favero, C Nielsen, BS Sørensen, J Bæch, K Grell, JW Hansen, ...
Leukemia, 1-13, 2020
32020
3-(2, 6-Dimethylphenyl)-2-Selenoxo-1, 3-Thiazolidin-4-One Suppresses Hydrogen Peroxide-Induced Cytotoxicity on PC12 Cells Via Activation of MAPK
A Nishina, H Kimura, K Kozawa, G Sommen, F Favero, H Heimgartner, ...
International Journal of Toxicology, 2011
32011
The system can't perform the operation now. Try again later.
Articles 1–20